Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients

Peritoneal Dialysis International

Volumn 26, Issue 2, 2006, Pages 191-197

  Yip, Terence ^a   Tse, Kai Chung ^a   Lam, Man Fai ^a   Tang, Sydney ^a   Li, Fu Keung ^a   Choy, Bo Ying ^a   Lui, Sing Leung ^a   Chan, Tak Mao ^a   Lai, Kar Neng ^a   Lo, Wai Kei ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cephalosporin; E coli; Extended spectrum beta lactamase; Gastric acid inhibitor; Peritonitis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IMIPENEM; NETILMICIN; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR; TOBRAMYCIN; VANCOMYCIN; BETA LACTAMASE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM ISOLATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DEATH; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG UTILIZATION; ESCHERICHIA COLI; FEMALE; HEALTH STATUS; HUMAN; KIDNEY FAILURE; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS; RISK ASSESSMENT; RISK FACTOR; SEPSIS; TREATMENT FAILURE; TREATMENT WITHDRAWAL; BIOSYNTHESIS; ENTEROBACTER INFECTION; ENZYMOLOGY; MICROBIOLOGY; MIDDLE AGED; PERITONITIS;

AGED; BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; RISK FACTORS;

EID: 33645510764     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600213     Document Type: Article

References (38)

1. Tranaeus A, Heimburger O, Lindholm B. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): diagnostic findings, therapeutic outcome and complications. Perit Dial Int 1989; 9:179-90.
2. Fried L, Abidi S, Bernardini J, Johnston JR, Piraino B. Hospitalization in peritoneal dialysis patients. Am J Kidney Dis 1999; 33:927-33.
3. Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7:2176-82.
4. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Ad Hoc Advisory Committee on Peritonitis Management of the International Society for Peritoneal Dialysis. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update [Published erratum appears in Perit Dial Int 2000; 20:828-9]. Perit Dial Int 2000; 20:396-411.
5. Bunke CM, Brier ME, Golper TA. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 1997; 52:524-9.
6. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein F. Differing outcomes of gram-positive and gram-negative peritonitis. Am J Kidney Dis 1998; 32:623-8.
7. Bradford PA, Urban C, Jaiswal A, Mariano N, Rasmussen BA, Projan SJ, et al. SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients [Published erratum appears in Antimicrob Agents Chemother 1995; 39: 1646]. Antimicrob Agents Chemother 1995; 39:899-905.
8. Rasmussen BA, Bradford PA, Quinn JP, Wiener J, Weinstein RA, Bush K. Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences. Antimicrob Agents Chemother 1993; 37:1989-92.
9. Einhorn AE, Neuhauser MM, Bearden DT, Quinn JP, Pendland SL. Extended-spectrum beta-lactamases: frequency, risk factors, and outcomes. Pharmacotherapy 2002; 22:14-20.
10. Ho PL, Tsang DN, Que TL, Ho M, Yuen KY. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong Kong. APMIS 2000; 108: 237-40.
11. Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A, et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 2000; 36:1009-13.
12. Krishnan M, Thodis E, Ikonomopoulos D, Vidgen E, Chu M, Bargman JM, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int 2002; 22:573-81.
13. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11:315-17.
14. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39:1211-33.
15. Jacoby GA, Medeiros AA. More extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1991; 35: 1697-704.
16. Philippon A, Labia R, Jacoby G. Extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1989; 33: 1131-6.
17. Sanders CC. Beta-lactamases of gram-negative bacteria: new challenges for new drugs. Clin Infect Dis 1992; 14: 1089-99.
18. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001; 32(Suppl 2):S94-103.
19. Mathai D, Lewis MT, Kugler KC, Pfaller MA, Jones RN; SENTRY Participants Group (North America). Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I - Results from the SENTRY Antimicrobial Surveillance Program (North America, 1998) [Published erratum appears in Diagn Microbiol Infect Dis 2001; 39:275]. Diagn Microbiol Infect Dis 2001; 39:105-16.
20. Saurina G, Quale JM, Manikal VM, Oydna E, Landman D. Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother 2000; 45:895-8.
21. Sader HS, Jones RN, Silva JB; SENTRY Participants Group (Latin America). Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns. Diagn Microbiol Infect Dis 2002; 44:281-8.
22. Gales AC, Sader HHS, Jones RN. Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 2002; 44:301-11.
23. Sader HS, Jones RN, Andrade-Baiocchi S, Biedenbach DJ; SENTRY Participants Group (Latin America). Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Diagn Microbiol Infect Dis 2002; 44:273-80.
24. Xiong Z, Zhu D, Zhang Y, Wang F. Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates. Zhonghua Yi Xue Za Zhi 2002; 82:1476-9.
25. Bell JM, Turnidge JD, Gales AC, Pfaller MA, Jones RN; Sentry APAC Study Group. Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiol Infect Dis 2002; 42:193-8.
26. Hsueh PR, Liu YC, Yang D, Yan JJ, Wu TL, Huang WK, et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist 2001; 7:373-82.
27. Schiappa DA, Hayden MK, Matushek MG, Hashemi FN, Sullivan J, Smith KY, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996; 174:529-36.
28. Lucet JC, Chevret S, Decre D, Vanjak D, Macrez A, Bedos JP, et al. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996; 22:430-6.
29. De Champs C, Rouby D, Guelon D, Sirot J, Sirot D, Beytout D, et al. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase. J Hosp Infect 1991; 18:5-13.
30. Stockbrugger RW, Cotton PB, Eugenides N, Bartholomew BA, Hill MJ, Walters CL. Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment. Gut 1982; 23:1048-54.
31. Reusser P, Zimmerli W, Scheidegger D, Marbet GA, Buser M, Gyr K. Role of gastric colonization in nosocomial infections and endotoxemia: a prospective study in neurosurgical patients on mechanical ventilation. J Infect Dis 1989; 160:414-21.
32. Cristiano P, Paradisi F. Can cimetidine facilitate infections by oral route. Lancet 1982; 2(8288):45.
33. Wingate DL. Acid reduction and recurrent enteritis. Lancet 1990; 335(8683):222.
34. Fried M, Siegrist H, Frei R, Froehlich F, Duroux P, Thorens J, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 1994; 35:23-6.
35. Caravaca F, Ruiz-Calero R, Dominguez C. Risk factors for developing peritonitis caused by micro-organisms of enteral origin in peritoneal dialysis patients. Perit Dial Int 1998; 18:41-5.
36. Park YH, Lee HC, Song HG, Jung S, Ryu SH, Shin JW, et al. Recent increase in antibiotic-resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea. J Gastroenterol Hepatol 2003; 18:927-33.
37. Dryden MS, Talsania H, McCann M, Cookson BD, Phillips I. The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients. Epidemiol Infect 1992; 109:97-112.
38. Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper TA, et al. Advisory Committee on Peritonitis Management of the International Society for Peritoneal Dialysis. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996; 16: 557-73.